Article IV: Clinical application of pharmacokinetics

Journal of the American Veterinary Medical Association

Volumn 213, Issue 10, 1998, Pages 1418-1420

  Martinez, Marilyn N ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG RESIDUE; VETERINARY DRUG;

ANIMAL; AREA UNDER THE CURVE; DOSE RESPONSE; DRUG LABELING; HALF LIFE TIME; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG LABELING; DRUG RESIDUES; HALF-LIFE; VETERINARY DRUGS;

EID: 0032534087     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Martinez, M. Article I: Noncompartmentalized methods of drug characterization: statistical moment theory. J Am Vet Med Assoc 1998;213:974-980.
2. Martinez, M. Article II: Volume, clearance, and half-life. J Am Vet Med Assoc 1998;213:1122-1127.
3. Martinez, M. Article III: Physicochemical properties of pharmaceuticals. J Am Vet Med Assoc 1998;213:1274-1277.
4. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, Inc, 1982.
5. Benet LZ, Sheiner LB. Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In: AG Gilman, LS Goodman, TW Rall, et al, eds. Goodman and Gilman's Pharmacological Basis of Therapeutics. New York: Macmillan Publishing Co 1985;3-48.
6. Benet LZ, Zia-Amirhosseini P. Basic principles of pharmacokinetics. Tox Path 1995;23:115-123.
7. Riviere JE. Pharmacologic principles of residue avoidance for veterinary practitioners. J Am Vet Med Assoc 1991;198:809-819.
8. Vogelman B, Gudmundsson S, Leggett J, et al. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 1988;158:831-847.
9. Koritz GD, Bevill RF. Role of pharmacokinetics in the outcome of treatment of infections. Acta Scand Vet 1991;87:18-26.
10. Ebert SC. Pharmacokinetic-pharmacodynamic modeling of irreversible drug effects. In: Derendorf H, Hochhaus G, eds. Handbook of Pharmacokinetic/Pharmacodynamic Correlation. Boca Raton, Florida: CRC Press, 1995;35-56.
11. Ferguson DC. Rational empirical antimicrobial therapy in small animals, in Proceedings. Int Symp AntimicrobSelect N Am Vet Conf 1994;1-11.
12. Craig WA, Gudmundsson S. Postantibiotic effect. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 2nd ed. Baltimore: Williams and Wilkins, 1986;403-431.
13. Craig WA, Vogelman B. The postantibiotic effect. Ann Int Med 1987;106:900-902.
14. Craig W. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens. Eur J Clin Microbiol Infect Dis 1993;1(Suppl):6-8.
15. Zhanel GC, Craig WA. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides Clin Pharmacokinetics 1993;27:377-392.
16. Klepser ME, Marrangos MN, Patel KB, et al. Clinical pharmacokinetics of newer cephalosporins. Clin Pharmacokinetics 1995;28:361-384.
17. Schwab JC, Mandell GL. The importance of penetration of antimicrobial agents into cells. Infect Dis Clin N Am 1989;3:461-467.
18. Butts JD. Intracellular concentrations of antibacterial agents and related clinical implications. Clin Pharmacokinetics 1994;27:63-84.
19. Bundtzen RW, Gerger AU, Cohn DL, et al. Postantibiotic suppression on bacterial growth. Rev Infect Dis 1981;3:28-37.
20. Bevill RF. Sulfonamides. In: Booth NH, McDonald LE, eds. Veterinary pharmacology and therapeutics. 6th ed. Ames, Iowa: Iowa State University Press, 1988;785-795.
21. van den Broek PJ. Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis 1989;11:213-245.
22. Nolting A, Derendorf H. Handbook of pharmacokinetic/ pharmacodynamic correlation. Boca Raton, Florida: CRC Press, 1995;363-388.
23. Prescott JF, Baggot JD. Antimicrobial therapy in veterinary medicine. Ames, Iowa: Iowa State University Press, 1993.
24. Van Duijkeren E, Vulto AG, Van Miert ASJPAM. Trimethoprim/sulfonamide combinations in the horse: a review. J Vet Pharm Therap 1994;17:64-73.
25. Tulkens PM. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections. Scand J Inject Dis 1991;74(Suppl):209-217.
26. Barza M. Pharmacokinetics of antibiotics. In: L.D. Sabath, ed. Action of antibiotics in patients. Vienna, Austria: Hans Huber Publishers, 1982;11-39.
27. Vogelman B, Craig WA. Kinetics of antimicrobial activity. J Pediatrics 1986;108:835-840.
28. McDonald PJ, Wetherall BL, Pruul H. Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes. Rev Infect Dis 1981;3:38-44.
29. Minguez F, Ramos C, Barrientos S, et al. Postantibiotic effect of ciprofloxacin compared with that of five other fluoroquinolones. Chemotherap 1991;37:420-425.
30. Zhanel GG, Karlowsky, JA, Davidson RJ, et al. Influence of human urine on the postantibiotic effect (PAE) of ciprofloxacin against Escherichia coli. J Clin Exp Chemotherap 1991;37:218-223.
31. Zhanel GG, Karlowsky JA, Davidson RJ, et al. Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin and gentamicin against Escherichia coli. Antimicrob Agents Chemotherap 1992;36:1136-1139.
32. Davidson RJ, Zhanel GG, Hoban DJ. Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus. Antimicrob Agents Chemotherap 1991;35:1261-1263.
33. Levy G, Ebling WF, Forrest A. Concentration-or effect-controlled clinical trials with sparse data. Clin Pharm Therap 1994;56:1-8.